Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Cancers|December 17, 2024
Impact of Patient's Age and Physician's Professional Background on the Number Needed to Treat in Malignant Melanoma DetectionLaura Schreieder, Veronika Zenderowski, Mark Berneburg, et al.
Biology|July 26, 2024
Retrospective Single-Center Case Study of Clinical Variables and the Degree of Actinic Elastosis Associated with Rare Skin CancersKonstantin Drexler, Lara Bollmann, Sigrid Karrer, et al.
Advances in Therapy|October 1, 2021
Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in BavariaKonstantin Drexler, Hans Drexler, Edward K Geissler, et al.
Aging Cell|October 10, 2008
p16INK4a-induced senescence is disabled by melanoma-associated mutationsSebastian Haferkamp, Therese M Becker, Lyndee L Scurr, et al.
Angewandte Chemie (International Ed. in English)|April 2, 2018
In Situ Investigations of Mechanochemical One-Pot SynthesesHannes Kulla, Sebastian Haferkamp, Irina Akhmetova, et al.
Oncogenesis|September 22, 2018
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1Johannes Grimm, Anita Hufnagel, Marion Wobser, et al.
International Journal of Cancer|September 12, 2014
Characterization of functional domains in the Merkel cell polyoma virus Large T antigenRoland Houben, Sabrina Angermeyer, Sebastian Haferkamp, et al.
Cell Cycle (Georgetown, Tex.)|May 16, 2013
α-Fucosidase as a novel convenient biomarker for cellular senescenceDominic G Hildebrand, Simon Lehle, Andreas Borst, et al.
Future Oncology (London, England)|February 14, 2020
Real-world use of talimogene laherparepvec in Germany: a retrospective observational study using a prescription databaseKarly S Louie, Victoria Banks, Florian Scholz, et al.
The Journal of Investigative Dermatology|February 13, 2009
Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressorsSebastian Haferkamp, Lyndee L Scurr, Therese M Becker, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Cancers|December 17, 2024
Impact of Patient's Age and Physician's Professional Background on the Number Needed to Treat in Malignant Melanoma DetectionLaura Schreieder, Veronika Zenderowski, Mark Berneburg, et al.
Biology|July 26, 2024
Retrospective Single-Center Case Study of Clinical Variables and the Degree of Actinic Elastosis Associated with Rare Skin CancersKonstantin Drexler, Lara Bollmann, Sigrid Karrer, et al.
Advances in Therapy|October 1, 2021
Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in BavariaKonstantin Drexler, Hans Drexler, Edward K Geissler, et al.
Aging Cell|October 10, 2008
p16INK4a-induced senescence is disabled by melanoma-associated mutationsSebastian Haferkamp, Therese M Becker, Lyndee L Scurr, et al.
Angewandte Chemie (International Ed. in English)|April 2, 2018
In Situ Investigations of Mechanochemical One-Pot SynthesesHannes Kulla, Sebastian Haferkamp, Irina Akhmetova, et al.
Oncogenesis|September 22, 2018
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1Johannes Grimm, Anita Hufnagel, Marion Wobser, et al.
International Journal of Cancer|September 12, 2014
Characterization of functional domains in the Merkel cell polyoma virus Large T antigenRoland Houben, Sabrina Angermeyer, Sebastian Haferkamp, et al.
Cell Cycle (Georgetown, Tex.)|May 16, 2013
α-Fucosidase as a novel convenient biomarker for cellular senescenceDominic G Hildebrand, Simon Lehle, Andreas Borst, et al.
Future Oncology (London, England)|February 14, 2020
Real-world use of talimogene laherparepvec in Germany: a retrospective observational study using a prescription databaseKarly S Louie, Victoria Banks, Florian Scholz, et al.
The Journal of Investigative Dermatology|February 13, 2009
Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressorsSebastian Haferkamp, Lyndee L Scurr, Therese M Becker, et al.
Pageof 15